Country of Origin:
Germany

Key Features:

• Prevention of Preterm Labor: Reduces the risk of spontaneous preterm birth in women with a history of such births.
• Weekly Administration: Convenient weekly dosing from the 16th to the 37th week of pregnancy.
• Intramuscular Injection: Administered via deep intramuscular injection, preferably in the gluteal area.

Ingredients:

• Active Ingredient: Hydroxyprogesterone caproate 250 mg per 1 ml ampoule.
• Other Ingredients: Not specified.

How to Use:

• Dosage: 250 mg intramuscularly once a week.
• Administration: Administered by a healthcare professional via deep intramuscular injection.
• Treatment Duration: Start between the 16th and 20th week of pregnancy and continue until the 37th week or delivery.
• Precautions: Not intended for use in women pregnant with more than one baby (such as twins or triplets).